How dangerous are India’s generic drugs? Very


India relies on the weak oversight of developing countries that make up the bulk of its exports – that’s how it can continue to push substandard and often deadly medicines there. — Bloomberg

FOR a nation that seeks to claim the mantle of “pharmacy to the world,” India is scandalously short on regulatory oversight.

In the last six months, its generic cough syrups have killed dozens of children, its eye drops have caused blindness and its chemotherapy drugs have been contaminated.

Save 30% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 9.73/month

Billed as RM 9.73 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.63/month

Billed as RM 103.60 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
India , genericdrugs , regulation , oversight , scandals

Next In Business News

Swift Energy Tech subsidiary bags contracts worth RM18mil
Reneuco redesignates Mustakim Mat Nun to group MD
ISF Group IPO oversubscribed by over 31 times
Dayang subsidiary to purchase marine vessel for RM117.7mil
Ringgit eases slightly against greenback on caution amid renewed US-EU tariff tension
Maybank launches ROAR30 strategy plan, targets 13-14% ROE by 2030
Mitrajaya accepts RM42.81mil fourth variation order for data centre project
PJBumi acquires drilling rigs for RM162mil
Manforce secures Bursa approval for ACE Market IPO
Ancom Nylex reports higher 2Q net profit

Others Also Read